Sex ratio of multiple sclerosis in Canada: a longitudinal study

SM Orton, BM Herrera, IM Yee, W Valdar… - The Lancet …, 2006 - thelancet.com
SM Orton, BM Herrera, IM Yee, W Valdar, SV Ramagopalan, AD Sadovnick, GC Ebers
The Lancet Neurology, 2006thelancet.com
Background Incidence of multiple sclerosis is thought to be increasing, but this notion has
been difficult to substantiate. In a longitudinal population-based dataset of patients with
multiple sclerosis obtained over more than three decades, we did not show a difference in
time to diagnosis by sex. We reasoned that if a sex-specific change in incidence was
occurring, the female to male sex ratio would serve as a surrogate of incidence change.
Methods Since environmental risk factors seem to act early in life, we calculated sex ratios …
Background
Incidence of multiple sclerosis is thought to be increasing, but this notion has been difficult to substantiate. In a longitudinal population-based dataset of patients with multiple sclerosis obtained over more than three decades, we did not show a difference in time to diagnosis by sex. We reasoned that if a sex-specific change in incidence was occurring, the female to male sex ratio would serve as a surrogate of incidence change.
Methods
Since environmental risk factors seem to act early in life, we calculated sex ratios by birth year in 27 074 Canadian patients with multiple sclerosis identified as part of a longitudinal population-based dataset.
Findings
The female to male sex ratio by year of birth has been increasing for at least 50 years and now exceeds 3·2:1 in Canada. Year of birth was a significant predictor for sex ratio (p<0·0001, χ2=124·4; rank correlation r=0·84).
Interpretation
The substantial increase in the female to male sex ratio in Canada seems to result from a disproportional increase in incidence of multiple sclerosis in women. This rapid change must have environmental origins even if it is associated with a gene–environment interaction, and implies that a large proportion of multiple sclerosis cases may be preventable in situ. Although the reasons why incidence of the disease is increasing are unknown, there are major implications for health-care provision because lifetime costs of multiple sclerosis exceed £1 million per case in the UK.
thelancet.com